Disopyramide Phosphate Capsule, Extended Release shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting Aug 24, 2026 · last update Aug 24, 2026
Manufacturers: Pfizer Inc.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Norpace CR, Capsule, Extended Release, 100 mg (NDC 0025-2732-31) | Pfizer Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Aug 24, 2026 Updated Aug 24, 2026 Discontinued Aug 24, 2026 |
| Norpace CR, Capsule, Extended Release, 150 mg (NDC 0025-2742-31) | Pfizer Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Aug 24, 2026 Updated Aug 24, 2026 Discontinued Aug 24, 2026 |